Physician profile
Basel Sharaf
NPI 1770567604
$1,157.69
in general payments reported to CMS, 2019-2025
9 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.98 · 2021: $73.87 · 2022: $97.80 · 2023: $224 · 2024: $516 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719 · Travel and Lodging: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.63 |
| Travel and Lodging | $177.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $369.21 | 2024 | Stealthstation S8 Platform |
| Mentor Worldwide LLC | $223.67 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Davol INC. | $156.46 | 2025 | |
| Axogen | $100.75 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Integra Lifesciences Corporation | $89.98 | 2019 | |
| Allergan, INC. | $73.87 | 2021 | |
| Depuy Synthes Sales INC. | $54.42 | 2022 | |
| Abbott Laboratories | $45.95 | 2024 | Infinity |
| Bioventus LLC | $43.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basel Sharaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.